journal article·2021-06Open access

Spontaneous formation of β-sheet nano-barrels during the early aggregation of Alzheimer’s amyloid beta

Yunxiang Sun, Aleksandr Kakinen, Xulin Wan, Niamh Moriarty, Cameron P.J. Hunt, Yuhuan Li, Nicholas Andrikopoulos, Aparna Nandakumar, Thomas P. Davis, Clare L. Parish, Yang Song, Pu Chun Ke, Feng Ding

Nano Today· Volume 38

Abstract

Soluble low-molecular-weight oligomers formed during the early aggregation of amyloid peptides have been hypothesized as a major toxic species of amyloidogenesis. Herein, we performed the first synergic in silico, in vitro and in vivo validations of the structure, dynamics and toxicity of Aβ42 oligomers. Aβ peptides readily assembled into β-rich oligomers comprised of extended β-hairpins and β-strands. Nanosized β-barrels were observed with certainty with simulations, transmission electron microscopy and Fourier transform infrared spectroscopy, corroborated by immunohistochemistry, cell viability, apoptosis, inflammation, autophagy and animal behavior assays. Secondary and tertiary structural proprieties of these oligomers, such as the sequence regions with high β-sheet propensities and inter-residue contact frequency patterns, were similar to the properties known for Aβ fibrils. The unambiguous spontaneous formation of β-barrels in the early aggregation of Aβ42 supports their roles as the common toxic intermediates in Alzheimer's pathobiology and a target for Alzheimer's therapeutics.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Alzheimer's disease research and treatments · Supramolecular Self-Assembly in Materials · Cholinesterase and Neurodegenerative Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (94)

Show source-provided references
1. A new era for understanding amyloid structures and disease10.1038/s41580-018-0060-8 ↗
2. Polymorphism in Alzheimer Aβ amyloid organization reflects conformational selection in a rugged energy landscape10.1021/cr900377t ↗
3. Key peptides and proteins in Alzheimer’s disease10.2174/1389203720666190103123434 ↗
4. Molecular structure of β-amyloid fibrils in Alzheimer’s disease brain tissue10.1016/j.cell.2013.08.035 ↗
5. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases10.1038/nature12481 ↗
6. Ke · Adv. Mater. · 2019
7. Implications of peptide assemblies in amyloid diseases10.1039/C7CS00372B ↗
8. Alzheimer’s and Parkinson’s diseases: the prion concept in relation to assembled A, tau, and -synuclein10.1126/science.1255555 ↗
9. Aggregation kinetics of the Aβ1–40 peptide monitored by NMR10.1039/C8CC01710G ↗
10. Secondary nucleation in amyloid formation10.1039/C8CC02204F ↗
11. Cholesterol catalyses Aβ42 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes10.1038/s41557-018-0031-x ↗
12. Small-molecule conversion of toxic oligomers to nontoxic β-sheet–rich amyloid fibrils10.1038/nchembio.719 ↗
13. The toxic Aβ oligomer and Alzheimer’s disease: an emperor in need of clothes10.1038/nn.3028 ↗
14. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis10.1126/science.1079469 ↗
15. Atomic-level study of the effects of O4 molecules on the structural properties of protofibrillar aβ trimer: β-sheet stabilization, salt bridge protection, and binding mechanism10.1021/jp508122t ↗
16. Mitigating human IAPP amyloidogenesis in vivo with chiral silica nanoribbons10.1002/smll.201802825 ↗
17. Cofibrillization of pathogenic and functional amyloid proteins with gold nanoparticles against amyloidogenesis10.1021/acs.biomac.7b01359 ↗
18. Amyloid β protein and Alzheimer’s disease: when computer simulations complement experimental studies10.1021/cr500638n ↗
19. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics10.1126/science.1072994 ↗
20. Identification and characterization of key kinetic intermediates in amyloid β-protein fibrillogenesis11Edited by F. Cohen10.1006/jmbi.2001.4970 ↗
21. Solution NMR studies of the Aβ(1−40) and Aβ(1−42) peptides establish that the met35 oxidation state affects the mechanism of amyloid formation10.1021/ja036813f ↗
22. Structure-neurotoxicity relationships of amyloid -protein oligomers10.1073/pnas.0905127106 ↗
23. Fibril structure of amyloid-β(1–42) by cryo–electron microscopy10.1126/science.aao2825 ↗
24. Molecular structure of an N-terminal phosphorylated β-amyloid fibril10.1073/pnas.1818530116 ↗
25. Atomic resolution structure of monomorphic Aβ42amyloid fibrils10.1021/jacs.6b05129 ↗
26. Atomic-resolution structure of a disease-relevant Aβ(1–42) amyloid fibril10.1073/pnas.1600749113 ↗
27. Aβ(1–42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer’s disease10.1038/nsmb.2991 ↗
28. Atomic-resolution three-dimensional structure of amyloid β fibrils bearing the Osaka mutation10.1002/anie.201408598 ↗
29. Molecular structural basis for polymorphism in Alzheimer’s -amyloid fibrils10.1073/pnas.0806270105 ↗
30. Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective10.1021/ar200189b ↗
31. Common molecular mechanism of amyloid pore formation by Alzheimer’s β-amyloid peptide and α-synuclein10.1038/srep28781 ↗
32. Amyloid toxicity in Alzheimer’s disease10.1515/revneuro-2017-0063 ↗
33. Question order and student understanding of structure and function10.1152/advan.00182.2017 ↗
34. Improving the precision of the structure–function relationship by considering phylogenetic context
35. Atomic view of a toxic amyloid small oligomer10.1126/science.1213151 ↗
36. Amyloid β-protein c-terminal fragments: formation of cylindrins and β-barrels10.1021/jacs.5b09536 ↗
37. Membrane binding and pore formation by a cytotoxic fragment of amyloid β peptide10.1021/acs.jpcb.7b07002 ↗
38. Structure of amyloid β25–35 in lipid environment and cholesterol-dependent membrane pore formation10.1038/s41598-019-38749-7 ↗
39. Aβ42 assembles into specific β-barrel pore-forming oligomers in membrane-mimicking environments10.1073/pnas.1605104113 ↗
40. Native ion mobility-mass spectrometry reveals the formation of β-barrel shaped amyloid-β hexamers in a membrane-mimicking environment10.1021/jacs.9b04596 ↗
41. Structure and dynamics of small soluble Aβ(1–40) oligomers studied by top-down hydrogen exchange mass spectrometry10.1021/bi3002049 ↗
42. Beta-barrel models of soluble amyloid beta oligomers and annular protofibrils: models of Aβ oligomers and protofibrils10.1002/prot.22832 ↗
43. The stability of cylindrin β-barrel amyloid oligomer models-A molecular dynamics study: molecular dynamics study of cylindrin10.1002/prot.24302 ↗
44. Tetrameric Aβ40 and Aβ42 β-barrel structures by extensive atomistic simulations. I. In a bilayer mimicking a neuronal membrane10.1021/acs.jpcb.9b01206 ↗
45. Tetrameric Aβ40 and Aβ42 β-barrel structures by extensive atomistic simulations. II. In aqueous solution10.1021/acs.jpcb.9b05288 ↗
46. Impact of A2T and D23N mutations on tetrameric Aβ42 barrel within a dipalmitoylphosphatidylcholine lipid bilayer membrane by replica exchange molecular dynamics10.1021/acs.jpcb.9b11881 ↗
47. Impact of Cu(II) binding on structures and dynamics of Aβ42monomer and dimer: molecular dynamics study10.1021/acschemneuro.6b00109 ↗
48. Aβ monomers transiently sample oligomer and fibril-like configurations: ensemble characterization using a combined MD/NMR approach10.1016/j.jmb.2013.06.021 ↗
49. An original monomer sampling from a ready‐made Aβ42NMR fibril suggests a turn‐β‐strand synergetic seeding mechanism10.1002/cphc.201801137 ↗
50. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study10.1039/C6CP01014H ↗
51. Insilicoinvestigation on the inhibition of Aβ42aggregation by Aβ40peptide by potential of mean force study10.1080/07391102.2017.1296783 ↗
52. Norepinephrine inhibits Alzheimer’s amyloid-β peptide aggregation and destabilizes amyloid-β protofibrils: a molecular dynamics simulation study10.1021/acschemneuro.8b00537 ↗
53. Aβ(16–22) peptides can assemble into ordered β-barrels and bilayer β-sheets, while substitution of phenylalanine 19 by tryptophan increases the population of disordered aggregates10.1021/jp405869a ↗
54. Distinct oligomerization and fibrillization dynamics of amyloid core sequences of amyloid-beta and islet amyloid polypeptide10.1039/C7CP05695H ↗
55. Effects of surface interactions on peptide aggregate morphology10.1063/1.3624929 ↗
56. Low molecular weight oligomers of amyloid peptides display β-barrel conformations: a replica exchange molecular dynamics study in explicit solvent10.1063/1.3385470 ↗
57. Self-assembly of the β2-microglobulin NHVTLSQ peptide using a coarse-grained protein model reveals a β-barrel species10.1021/jp710592v ↗
58. Graphene quantum dots rescue protein dysregulation of pancreatic β-cells exposed to human islet amyloid polypeptide10.1007/s12274-019-2520-7 ↗
59. Amyloid self‐assembly of hIAPP8‐20 via the accumulation of helical oligomers, α‐helix to β‐sheet transition, and formation of β‐barrel intermediates
60. Sun · Biochim. Biophys. Acta Mol. Basis Dis. · 2019 · 1865 · 43410.1016/j.bbadis.2018.11.021 ↗
61. Applications of discrete molecular dynamics in biology and medicine10.1016/j.sbi.2015.11.001 ↗
62. Cysteine to serine conversion at 111th position renders the disaggregation and retains the stabilization of detrimental SOD1 A4V mutant against amyotrophic lateral sclerosis in human—a discrete molecular dynamics study10.1007/s12013-017-0830-5 ↗
63. Solving protein structures using short-distance cross-linking constraints as a guide for discrete molecular dynamics simulations10.1126/sciadv.1700479 ↗
64. Amphiphilic surface chemistry of fullerenols is necessary for inhibiting the amyloid aggregation of alpha-synuclein NACore10.1039/C9NR02407G ↗
65. β-barrel oligomers as common intermediates of peptides self-assembling into cross-β aggregates10.1038/s41598-018-28649-7 ↗
66. Ge · Biochim. Biophys. Acta Biomembr. · 2018 · 1860 · 168710.1016/j.bbamem.2018.03.011 ↗
67. Amyloid -protein (A) assembly: a 40 and A 42 oligomerize through distinct pathways10.1073/pnas.222681699 ↗
68. Aβ42 pentamers/hexamers are the smallest detectable oligomers in solution10.1038/s41598-017-02370-3 ↗
69. Molecular dynamics simulations reveal the mechanism of graphene oxide nanosheet inhibition of Aβ1–42peptide aggregation10.1039/C9CP01803D ↗
70. The Alzheimer’s peptides Aβ40 and 42 adopt distinct conformations in water: a combined MD / NMR study10.1016/j.jmb.2007.02.093 ↗
71. Stabilization of a β-hairpin in monomeric Alzheimer’s amyloid-β peptide inhibits amyloid formation10.1073/pnas.0711731105 ↗
72. Human islet amyloid polypeptide monomers form ordered β-hairpins: a possible direct amyloidogenic precursor10.1021/ja903814q ↗
73. Distinct primary nucleation of polymorphic Aβ dimers yields to distinguished fibrillation pathways10.1021/acschemneuro.9b00437 ↗
74. Identification of hot regions of the Aβ-IAPP interaction interface as high-affinity binding sites in both cross- and self-association10.1002/anie.200904902 ↗
75. A free energy barrier caused by the refolding of an oligomeric intermediate controls the lag time of amyloid formation by hIAPP10.1021/jacs.7b08830 ↗
76. Amyloid-β forms fibrils by nucleated conformational conversion of oligomers10.1038/nchembio.624 ↗
77. Alzheimer’s amyloid-β A2T variant and its N-terminal peptides inhibit amyloid-β fibrillization and rescue the induced cytotoxicity
78. The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-β (Aβ) aggregation10.1074/jbc.M114.599027 ↗
79. Amyloid β-protein assembly: differential effects of the protective A2T mutation and recessive A2V familial Alzheimer’s disease mutation10.1021/acschemneuro.5b00171 ↗
80. A2T and A2V Aβ peptides exhibit different aggregation kinetics, primary nucleation, morphology, structure, and LTP inhibition: alternate hypothesis to A2T AD protection10.1002/prot.24995 ↗
81. Effects of the english (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid β-protein assembly and toxicity10.1074/jbc.M109.086496 ↗
82. The Tottori (D7N) and english (H6R) familial Alzheimer disease mutations accelerate Aβ fibril formation without increasing protofibril formation10.1074/jbc.M608220200 ↗
83. E22G pathogenic mutation of β-amyloid (Aβ) enhances misfolding of Aβ40 by unexpected prion-like cross talk between Aβ42 and Aβ4010.1021/jacs.7b13660 ↗
84. On the role of sidechain size and charge in the aggregation of Aβ42 with familial mutations10.1073/pnas.1803539115 ↗
85. Diverse structural conversion and aggregation pathways of Alzheimerʼs amyloid-β (1–40)10.1021/acsnano.9b01578 ↗
86. NMR-based site-resolved profiling of β-amyloid misfolding reveals structural transitions from pathologically relevant spherical oligomer to fibril10.1074/jbc.RA119.008522 ↗
87. Sclerotiorin stabilizes the assembly of nonfibrillar abeta42 oligomers with low toxicity, seeding activity, and beta-sheet content10.1016/j.jmb.2020.01.033 ↗
88. The α-to-β conformational transition of Alzheimer’s Aβ-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of β conformation seeding10.1002/cbic.200500223 ↗
89. Discrete molecular dynamics approach to the study of disordered and aggregating proteins10.1021/acs.jctc.6b01153 ↗
90. Ab initio RNA folding by discrete molecular dynamics: from structure prediction to folding mechanisms10.1261/rna.894608 ↗
91. Probing protein aggregation using discrete molecular dynamics10.2741/3039 ↗
92. Effective energy function for proteins in solution10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N ↗
93. Mechanism for the alpha-helix to beta-hairpin transition10.1002/prot.10468 ↗
94. Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features10.1002/bip.360221211 ↗